{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T06:36:48Z","timestamp":1776753408503,"version":"3.51.2"},"reference-count":23,"publisher":"Oxford University Press (OUP)","issue":"22","license":[{"start":{"date-parts":[[2021,6,10]],"date-time":"2021-06-10T00:00:00Z","timestamp":1623283200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/N013468\/1"],"award-info":[{"award-number":["MR\/N013468\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,11,18]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Motivation<\/jats:title>\n                    <jats:p>Monoclonal antibody (mAb) therapeutics are often produced from non-human sources (typically murine), and can therefore generate immunogenic responses in humans. Humanization procedures aim to produce antibody therapeutics that do not elicit an immune response and are safe for human use, without impacting efficacy. Humanization is normally carried out in a largely trial-and-error experimental process. We have built machine learning classifiers that can discriminate between human and non-human antibody variable domain sequences using the large amount of repertoire data now available.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Our classifiers consistently outperform the current best-in-class model for distinguishing human from murine sequences, and our output scores exhibit a negative relationship with the experimental immunogenicity of existing antibody therapeutics. We used our classifiers to develop a novel, computational humanization tool, Hu-mAb, that suggests mutations to an input sequence to reduce its immunogenicity. For a set of therapeutic antibodies with known precursor sequences, the mutations suggested by Hu-mAb show substantial overlap with those deduced experimentally. Hu-mAb is therefore an effective replacement for trial-and-error humanization experiments, producing similar results in a fraction of the time.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Availability and implementation<\/jats:title>\n                    <jats:p>Hu-mAb (humanness scoring and humanization) is freely available to use at opig.stats.ox.ac.uk\/webapps\/humab.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Supplementary information<\/jats:title>\n                    <jats:p>Supplementary data are available at Bioinformatics online.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/bioinformatics\/btab434","type":"journal-article","created":{"date-parts":[[2021,6,9]],"date-time":"2021-06-09T15:24:34Z","timestamp":1623252274000},"page":"4041-4047","source":"Crossref","is-referenced-by-count":117,"title":["Humanization of antibodies using a machine learning approach on large-scale repertoire data"],"prefix":"10.1093","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5931-2437","authenticated-orcid":false,"given":"Claire","family":"Marks","sequence":"first","affiliation":[{"name":"Department of Statistics, University of Oxford , Oxford OX1 3LB, UK"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3023-2588","authenticated-orcid":false,"given":"Alissa M","family":"Hummer","sequence":"additional","affiliation":[{"name":"Department of Statistics, University of Oxford , Oxford OX1 3LB, UK"}]},{"given":"Mark","family":"Chin","sequence":"additional","affiliation":[{"name":"Department of Statistics, University of Oxford , Oxford OX1 3LB, UK"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1388-2252","authenticated-orcid":false,"given":"Charlotte M","family":"Deane","sequence":"additional","affiliation":[{"name":"Department of Statistics, University of Oxford , Oxford OX1 3LB, UK"}]}],"member":"286","published-online":{"date-parts":[[2021,6,10]]},"reference":[{"key":"2023051607121889000_btab434-B1","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S1359-6446(03)02953-2","article-title":"Minimizingthe immunogenicity of protein therapeutics","volume":"9","author":"Chirino","year":"2004","journal-title":"Drug Discov. Today"},{"key":"2023051607121889000_btab434-B2","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1080\/19420862.2015.1076600","article-title":"Antibody humanization by structure-based computational protein design","volume":"7","author":"Choi","year":"2015","journal-title":"mAbs"},{"key":"2023051607121889000_btab434-B3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-32986-y","article-title":"Humanization of antibodies using a statistical inference approach","volume":"8","author":"Clavero-Alvarez","year":"2018","journal-title":"Sci. Rep"},{"key":"2023051607121889000_btab434-B4","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1093\/bioinformatics\/btv552","article-title":"ANARCI: antigen receptor numbering and receptor classification","volume":"32","author":"Dunbar","year":"2016","journal-title":"Bioinformatics"},{"key":"2023051607121889000_btab434-B5","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4161\/19420862.2015.989042","article-title":"The therapeutic monoclonal antibody market","volume":"7","author":"Ecker","year":"2015","journal-title":"mAbs"},{"key":"2023051607121889000_btab434-B6","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/0022-2836(92)91010-M","article-title":"Antibody framework residues affecting the conformation of the hypervariable loops","volume":"224","author":"Foote","year":"1992","journal-title":"J. Mol. Biol"},{"key":"2023051607121889000_btab434-B7","doi-asserted-by":"crossref","first-page":"3150","DOI":"10.1093\/bioinformatics\/bts565","article-title":"CD-HIT: accelerated for clustering the next-generation sequencing data","volume":"28","author":"Fu","year":"2012","journal-title":"Bioinformatics"},{"key":"2023051607121889000_btab434-B8","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/1472-6750-13-55","article-title":"Monoclonal antibody humanness score and its applications","volume":"13","author":"Gao","year":"2013","journal-title":"BMC Biotechnol"},{"key":"2023051607121889000_btab434-B9","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ymeth.2005.01.001","article-title":"Immunogenicity of engineered antibodies","volume":"36","author":"Hwang","year":"2005","journal-title":"Methods"},{"key":"2023051607121889000_btab434-B10","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/321522a0","article-title":"Replacing the complementarity-determining regions in a human antibody with those from a mouse","volume":"321","author":"Jones","year":"1986","journal-title":"Nature"},{"key":"2023051607121889000_btab434-B11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/19420862.2015.1114320","article-title":"The INNs and outs of antibody nonproprietary names","volume":"8","author":"Jones","year":"2016","journal-title":"mAbs"},{"key":"2023051607121889000_btab434-B12","doi-asserted-by":"crossref","first-page":"3694","DOI":"10.4049\/jimmunol.1800669","article-title":"Filtering next-generation sequencing of the Ig gene repertoire data using antibody structural information","volume":"201","author":"Kovaltsuk","year":"2018","journal-title":"J. Immunol"},{"key":"2023051607121889000_btab434-B13","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.4049\/jimmunol.1800708","article-title":"Observed antibody space: a resource for data mining next-generation sequencing of antibody repertoires","volume":"201","author":"Kovaltsuk","year":"2018","journal-title":"J. Immunol"},{"key":"2023051607121889000_btab434-B14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12929-019-0592-z","article-title":"Development of therapeutic antibodies for the treatment of diseases","volume":"27","author":"Lu","year":"2020","journal-title":"J. Biomed. Sci"},{"key":"2023051607121889000_btab434-B15","doi-asserted-by":"crossref","first-page":"6851","DOI":"10.1073\/pnas.81.21.6851","article-title":"Chimeric human antibody molecules: mouse antigen-binding domains with human constant region domains","volume":"81","author":"Morrison","year":"1984","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2023051607121889000_btab434-B16","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1093\/bioinformatics\/btu667","article-title":"Tabhu: tools for antibody humanization","volume":"31","author":"Olimpieri","year":"2015","journal-title":"Bioinformatics"},{"key":"2023051607121889000_btab434-B17","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1080\/19420862.2017.1341029","article-title":"Changes to international nonproprietary names for antibody therapeutics 2017 and beyond: of mice, men and more","volume":"9","author":"Parren","year":"2017","journal-title":"mAbs"},{"key":"2023051607121889000_btab434-B18","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1016\/S0007-4551(15)31081-X","article-title":"IMGT\/mAb-DB: the basis of IMGT data of therapeutic monoclonal antibodies","volume":"97","author":"Poiron","year":"2010","journal-title":"Bull. Cancer"},{"key":"2023051607121889000_btab434-B19","doi-asserted-by":"crossref","first-page":"D383","DOI":"10.1093\/nar\/gkz827","article-title":"Thera-SAbDab: the therapeutic structural antibody database","volume":"48","author":"Raybould","year":"2020","journal-title":"Nucl. Acids Res"},{"key":"2023051607121889000_btab434-B20","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1080\/02648725.2013.801235","article-title":"Antibody humanization methods\u2014a review and update","volume":"29","author":"Safdari","year":"2013","journal-title":"Biotechnol. Genet. Eng. Rev"},{"key":"2023051607121889000_btab434-B21","doi-asserted-by":"crossref","first-page":"e76909","DOI":"10.1371\/journal.pone.0076909","article-title":"Development of scoring functions for antibody sequence assessment and optimization","volume":"8","author":"Seeliger","year":"2013","journal-title":"PLoS One"},{"key":"2023051607121889000_btab434-B22","first-page":"319","volume-title":"Antibody Engineering (Springer Protocols Handbooks)","author":"Williams","year":"2010"},{"key":"2023051607121889000_btab434-B23","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/protein\/gzz031","article-title":"Quantifying the nativeness of antibody sequences using long short-term memory networks","volume":"32","author":"Wollacott","year":"2019","journal-title":"Protein Eng. Des. Sel"}],"container-title":["Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/bioinformatics\/advance-article-pdf\/doi\/10.1093\/bioinformatics\/btab434\/39109088\/btab434.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bioinformatics\/article-pdf\/37\/22\/4041\/50335362\/btab434.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bioinformatics\/article-pdf\/37\/22\/4041\/50335362\/btab434.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,16]],"date-time":"2023-05-16T03:30:02Z","timestamp":1684207802000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bioinformatics\/article\/37\/22\/4041\/6295884"}},"subtitle":[],"editor":[{"given":"Pier Luigi","family":"Martelli","sequence":"additional","affiliation":[]}],"short-title":[],"issued":{"date-parts":[[2021,6,10]]},"references-count":23,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2021,11,18]]}},"URL":"https:\/\/doi.org\/10.1093\/bioinformatics\/btab434","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.01.08.425894","asserted-by":"object"}]},"ISSN":["1367-4803","1367-4811"],"issn-type":[{"value":"1367-4803","type":"print"},{"value":"1367-4811","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,11,15]]},"published":{"date-parts":[[2021,6,10]]}}}